Cerus
CERS
#7539
Rank
C$0.54 B
Marketcap
C$2.86
Share price
-1.43%
Change (1 day)
13.00%
Change (1 year)

Revenue for Cerus (CERS)

Revenue in 2025 (TTM): C$0.27 Billion

According to Cerus's latest financial reports the company's current revenue (TTM ) is C$0.27 Billion. In 2024 the company made a revenue of C$0.25 Billion an increase over the revenue in the year 2023 that were of C$0.20 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cerus from 1997 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) C$0.27 B8.19%
2024 C$0.25 B24.73%
2023 C$0.20 B-5.68%
2022 C$0.21 B31.85%
2021 C$0.16 B42.29%
2020 C$0.11 B20.21%
2019 C$97.49 M17.51%
2018 C$82.96 M51.47%
2017 C$54.77 M9.62%
2016 C$49.96 M5.25%
2015 C$47.47 M12.34%
2014 C$42.26 M0.11%
2013 C$42.21 M15.98%
2012 C$36.39 M8.29%
2011 C$33.61 M45.51%
2010 C$23.09 M22.09%
2009 C$18.92 M-5.73%
2008 C$20.07 M91.25%
2007 C$10.49 M-74.67%
2006 C$41.42 M46%
2005 C$28.37 M69.82%
2004 C$16.7 M33.27%
2003 C$12.53 M-6.5%
2002 C$13.4 M85.61%
2001 C$7.22 M160.51%
2000 C$2.77 M-17.62%
1999 C$3.36 M-24.5%
1998 C$4.45 M-54.77%
1997 C$9.85 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Haemonetics
HAE
C$1.83 B 566.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
C$0 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
C$26.75 B 9,614.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
C$53.67 M-80.51%๐Ÿ‡บ๐Ÿ‡ธ USA